Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
about
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
description
article publié dans Nature Communications
@fr
im September 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Nature Communications
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2018
@uk
name
Methylation of all BRCA1 copie ...... rucaparib in ovarian carcinoma
@en
Methylation of all BRCA1 copie ...... rucaparib in ovarian carcinoma
@nl
type
label
Methylation of all BRCA1 copie ...... rucaparib in ovarian carcinoma
@en
Methylation of all BRCA1 copie ...... rucaparib in ovarian carcinoma
@nl
prefLabel
Methylation of all BRCA1 copie ...... rucaparib in ovarian carcinoma
@en
Methylation of all BRCA1 copie ...... rucaparib in ovarian carcinoma
@nl
P2093
P2860
P50
P1476
Methylation of all BRCA1 copie ...... rucaparib in ovarian carcinoma
@en
P2093
Alexander Dobrovic
Alison Hadley
Anna deFazio
Australian Ovarian Cancer Study (AOCS)
Elaine Sanij
Elizabeth Lieschke
Elizabeth M Swisher
Emma Boehm
Giada V Zapparoli
Gwo-Yaw Ho
P2860
P2888
P356
10.1038/S41467-018-05564-Z
P407
P50
P577
2018-09-28T00:00:00Z